EP3077415
REDUCTION OF INFLAMMATORY DISEASE SYMPTOMS BY SHORT PEPTIDES THAT INHIBIT SIGNALING THROUGH CD28
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.12.2014EP published:
12.2.2020EP application number:
14830734.1
EPO information:
European Patent Register
Max expiry date:
6.12.2034
Title:
REDUCTION OF INFLAMMATORY DISEASE SYMPTOMS BY SHORT PEPTIDES THAT INHIBIT SIGNALING THROUGH CD28
Timeline
Today
7.12.2014EP application
12.2.2020EP Publication
Owner
Name:
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.Address:
Hi Tech Park Edmond Safra Campus Givat-Ram, 9139002 Jerusalem, IL
Name:
Atox Bio Ltd.Address:
3 Golda Meir Street Weizmann Science Park, 74036 Ness Ziona, IL
Inventor
Name:
KAEMPFER, RaymondAddress:
9370719 Jerusalem, IL
Name:
SHIRVAN, AnatAddress:
4464500 Kfar-Saba, IL
Name:
ARAD, GilaAddress:
9079554 Mevasseret Zion, IL
Priority
Number:
201361912631 PDate:
6.12.2013Country:
US
Number:
201461924869 PDate:
8.1.2014Country:
US
Classification
Categories:
C07K 14/705, A61K 38/17